View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Brentuximab Vedotin 1.8 / Nivolumab 240, Non-Hodgkin Lymphoma, Cycle 2+
Protocol-ID: 1515 V1.0 (Mini), BRNT1.8/NIVO240, NHL, C2+Indication(s)
- NHL, B-Cell Type, Mediastinal (Thymic) Large B-Cell Lymphoma; ICD-10 C85.2
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 19.06.2020